02 September 2023 : Clinical Research
Antibiotic-Resistant Strains of Helicobacter pylori in 50 Antibiotic Treatment-Naive Children in Northeast Poland Diagnosed by Gastric or Duodenal Biopsy Between February 2019 and May 2022
Magdalena Kucharska
1ABCDEF*, Katarzyna Zdanowicz 1C, Tamara Daniluk 2BC, Robert Bucki 2DEF, Dariusz Marek Lebensztejn 1DEF, Urszula Daniluk 1CDF
DOI: 10.12659/MSM.941195
Med Sci Monit 2023; 29:e941195
Table 4 Characteristics of patients based on the time of EGD performed (before outbreak of the COVID-19 pandemic vs during the COVID-19 pandemic).
| Parameter | Patients before the outbreak of the COVID-19 pandemicn=29 | Patients during COVID-19 pandemicn=21 | p |
|---|---|---|---|
| Gender, Female n (%) | 13 (44.8%) | 13 (61.9%) | NS |
| Age, median (range) | 9.5 (5–17) | 11.5 (3–17) | NS |
| Resistance to AMX, n (%) | 8 (27.5%) | 5 (23.8%) | NA |
| Resistance to MTZ, n (%) | 9 (31.0%) | 6 (28.6%) | NA |
| Resistance to CL, n (%) | 11 (37.9%) | 8 (38.1%) | NA |
| History of antibiotic therapy, n (%) | 4 (13.8%) | 6 (28.5%) | NA |
| H. pylori in the family (1/2 degree relatives), n (%) | 9 (31.0%) | 10 (47.6%) | NA |
| Smoking household, n (%) | 6 (20.7%) | 10 (47.6%) | 0.04 |
| AMX – amoxicillin, MTZ – metronidazole, CL – clarithromycin. | |||